Clinical Trial Update: Study of Lumateperone in the Treatment of Patients With Bipolar Mania [Phase 3]

View source ↗

Summary

Lumateperone is being studied in a Phase 3 trial for manic episodes in bipolar disorder, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Lumateperone (lumateperone)

Snippet

Sponsor: Intra-Cellular Therapies, Inc. | Conditions: Bipolar Disorder, Manic | Phase 3 | Status: RECRUITING